10th Annual Cardiovascular Research Institute (CVRI) Symposium

Needs Statement

As medical research and technology change rapidly, it is increasingly important for physicians and healthcare professionals to stay informed of new evidence. Newly learned pathways can be used as potential mechanisms and alternative strategies in new research applications. This symposium is designed as a platform to share and discuss state-of-the-art ongoing, innovative, and new cardiovascular research with the ultimate goal of translating research into clinical practice. In addition, topics on how to apply new diagnostic and imaging techniques can create opportunities for collaboration with the developers of these techniques in new research protocols.

Educational Objectives

At the conclusion of the activity, participants should be able to:

• Summarize the novel molecular mechanisms of vascular disease.
• Discuss changes in the immune microenvironment in pediatric heart transplantation.
• Describe lineage determination from stem cell to cardiac progenitors to different types of cardiomyocytes.
• Discuss the regulatory mechanisms that lead to premature onset aging-related cardiovascular diseases observed in cancer survivors and their mitigation strategies.

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.